Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Insect' refers to a diverse class of invertebrate animals (Class Insecta) within the phylum Arthropoda, characterized by a chitinous exoskeleton, a three-part body, and three pairs of jointed legs [1]. In a pharmacological and therapeutic context, 'Insect' is not a specific molecular target (such as a receptor or enzyme) but rather a biological taxon that encompasses millions of species [1]. Insects are clinically significant primarily as vectors for human pathogens, such as Plasmodium (Malaria) or Flaviviruses (Dengue), and as sources of potent allergens and venoms [2]. While specific molecular structures within insects, such as the ryanodine receptor or the octopamine receptor, serve as valid targets for agrochemicals and pesticides, the broad designation 'Insect' is considered an incorrect entry for a discrete therapeutic target [3]. Treatment strategies involving insects generally focus on the prevention of vector-borne diseases, the management of systemic allergic reactions (anaphylaxis) to stings, or the topical eradication of ectoparasites like lice and scabies [4]. Sources: [1] Encyclopedia Britannica. (2023). "Insect." [2] World Health Organization (WHO). (2020). "Vector-borne diseases." [3] IRAC (Insecticide Resistance Action Committee). (2023). "MoA Classification Scheme." [4] National Institute of Allergy and Infectious Diseases (NIAID). (2022). "Insect Allergy."
Drugs interacting with insects (insecticides) typically function through the modulation of voltage-gated sodium channels, inhibition of acetylcholinesterase, or antagonism of GABA-gated chloride channels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insect.